- Market Size (2026)
- USD 6.4 Bn
- Forecast (2036)
- USD 9.6 Bn
- CAGR (2026 to 2036)
- 4.1%
How big is Kidney Transplant Market in 2026?
Demand is projected to expand at 4.1% CAGR from 2026 to 2036. Market value rises from USD 6.18 billion in 2025 to USD 6.4 billion in 2026 and USD 9.6 billion by 2036.
Growth depends on connecting an available organ with a suitable recipient and a transplant programme able to provide surgery and continuing treatment. Living donation allows evaluation and scheduling before surgery, whereas deceased donation places greater emphasis on rapid recovery, allocation and preservation. In the United Kingdom, paired exchanges provide another route for patients whose intended living donor is incompatible. Medicines, preservation equipment and specialist services address different purchasing needs within these programmes. Investment through 2036 is consequently likely to favour suppliers that support dependable treatment delivery and centres that can sustain follow-up after discharge, with organ availability and clinical capacity continuing to shape the pace of expansion.

Key Market Trends & Insights
- Functioning matching and financing pathways support completed treatment.
- Organ availability and specialist capacity can constrain conversion of need into procedures.
- Targeted support can address distinct bottlenecks within transplant services.
Regional Highlights
- Brazil's transplant activity is concentrated within an established network of centres, giving suppliers and service providers a clear institutional route into the market (FMI outlook: 4.1% CAGR, 2026 to 2036).
- Inclusion of a kidney-transplant package within Ayushman Bharat PM-JAY provides an identified financing route for eligible treatment in India, alongside the continuing need for specialist centres and suitable donors (FMI outlook: 3.3% CAGR, 2026 to 2036).
- Recovered-organ utilisation remains a practical issue for US transplant programmes, alongside the task of maintaining enough clinical capacity for recipients already evaluated for treatment (FMI outlook: 3.2% CAGR, 2026 to 2036).
Market Size & Forecast
Table 1: Market Size and Forecast for Kidney Transplant Market (USD billion and percentage), 2025 to 2036
| Metric | Value |
|---|---|
| 2025 market value | USD 6.18 billion |
| 2026 market value | USD 6.4 billion |
| 2036 market value | USD 9.6 billion |
| CAGR 2026 to 2036 | 4.1% |
| Revenue increase 2026 to 2036 | USD 3.2 billion |
| Market expansion 2026 to 2036 | 1.50 times |
The market covers kidney-transplant procedures and organ preservation together with related treatment and services. Kidney-only and multiorgan procedures are distinguished, as are donor sources and active versus total waiting lists.
Evaluation of transplant-related interventions creates demand for clinical trials that examine a defined product and recipient population.
The gap between listed need and realised transplantation
Transplant activity creates connected purchasing requirements across recipient treatment, donor coordination and specialist centres. The UK programme demonstrates paired exchange in operation, and Brazil's centre network identifies the institutions through which suppliers serve repeated procedures. Together, these observations show where medicines, preservation technology and clinical support enter the transplant pathway.
Table 2: Industry evidence relevant to the kidney transplant market
| Indicator | Data point or observation | Market relevance | Source |
|---|---|---|---|
| Paired exchange | 117 UK procedures enabled in 2025/26 | Documents an additional living-donor matching route | |
| Centre network | 162 active Brazilian centres in 2025 | Identifies an institutional route to transplant demand |
Analyst Perspective
"A kidney-transplant service depends on organ access and the clinical pathway surrounding the procedure. Equipment and pharmaceutical demand sit within that wider programme, with assessment, specialist capacity and continuing care shaping what an institution can deliver and the support it needs from suppliers."
- Anurag Sharma, Principal Consultant, FMI
How is the Kidney Transplant Market segmented?
The market is segmented by Transplant Type, Age Group, End User, Donor Type, Procedure Type, Post-Transplant Care, and Region.
The market is segmented by Transplant Type, Age Group, End User, Donor Type, Procedure Type and Post-Transplant Care. Transplant type distinguishes living-donor and deceased-donor procedures, age group separates adult and paediatric recipients, and the remaining categories describe the institutions, organ sources, surgical approaches and continuing treatment involved in delivering transplantation.
Why does living donation hold a substantial transplant-type share?

Table 3: Transplant Type Share for Kidney Transplant Market (percentage share), 2026
| Transplant Type | Estimated share (2026) |
|---|---|
| Living-Donor Kidney Transplant | 58.9% |
| Deceased-Donor Kidney Transplant | 41.1% |
| Total | 100.0% |
Table 4: Segment Position and Market Growth for Kidney Transplant Market, 2026 to 2036
| Metric | Value |
|---|---|
| Global CAGR (2026 to 2036) | 4.1% |
| Profiled transplant type segment | Living-Donor Kidney Transplant |
Living donation gives the transplant team time to evaluate the donor and recipient, arrange the operation and prepare the services needed after discharge. Its commercial importance therefore extends from the operating theatre to assessment, matching and continuing medicine supply. The UK Living Kidney Sharing Scheme demonstrates how paired and pooled exchange can enable procedures when an intended donor and recipient cannot proceed together. A centre developing this pathway needs coordination between donor and recipient teams, while the purchased medicines and clinical support remain tied to the recipient's ongoing needs. These linked requirements support the segment's projected position, with expansion depending on suitable donors and the capacity to carry an evaluated pair through to surgery.
The Living-Donor Kidney Transplant segment is projected to account for 58.9% of transplant type demand in 2026.
- Living-Donor Kidney Transplant: 58.9% of transplant-type demand (2026 estimate), supported by planned donor evaluation and scheduled procedures.
- Paired exchange connects otherwise incompatible donor-recipient pairs through a coordinated transplant programme, adding a practical matching route within living donation.
Why do adult recipients account for the larger age-group share?
Table 5: Age Group Share for Kidney Transplant Market (percentage share), 2026
| Age Group | Estimated share (2026) |
|---|---|
| Adult | 76.4% |
| Pediatric | 23.6% |
| Total | 100.0% |
Adult recipients form the larger treatment population served by kidney-transplant programmes, bringing a broad range of assessment, surgical and continuing-care requirements into the market. An adult programme needs to coordinate eligibility assessment, donor matching, surgery and immunosuppressive treatment while accounting for other health conditions that may affect suitability. Demand for medicines and follow-up consequently continues beyond the initial hospital admission. The segment's projected share reflects this extensive adult care pathway, with clinical eligibility and organ availability determining which assessed patients can proceed to transplantation.
The Adult segment is projected to account for 76.4% of age group demand in 2026.
- Adult: 76.4% of age-group demand (2026 estimate), reflecting the larger recipient population and its continuing treatment requirements.
- Recipient assessment and post-transplant monitoring connect the procedure with a longer course of specialist care and medicine purchasing.
- Healthcare interoperability helps transplant teams exchange the patient and laboratory information required across assessment and continuing care.
What are the drivers, restraints, and opportunities in the Kidney Transplant Market?
A transplant programme purchases a sequence of clinical capabilities around an available organ and a suitable recipient. Matching, preservation, surgery and continuing medicines each carry different responsibilities, making dependable coordination commercially important as centres expand. The opportunity through 2036 depends on supporting this sequence with appropriate clinical capacity and reliable supplies, while donor availability continues to influence the pace of completed treatment.
Driver
Living-donor evaluation and paired exchange help centres organise suitable procedures, while identified payment pathways can improve access to treatment for eligible recipients. The UK exchange programme and India's inclusion of a kidney-transplant package in PM-JAY illustrate how matching and financing support different parts of the same pathway. Demand develops when centres can combine these arrangements with specialist teams and continuing recipient care.
Restraint
Organ availability, clinical capacity and continuing-care requirements can constrain expansion. Preservation choices and centre readiness need to fit the circumstances of each organ and recipient.
Opportunity
Transplant networks offer opportunities for dependable organ handling, specialist coordination and continuing medicine supply, particularly where a centre manages repeated procedures across different donor pathways. Brazil's documented centre network illustrates the institutional route through which suppliers can address these needs. Commercial value follows a clearly defined product or service that supports the programme's actual caseload.
Laboratory informatics supports the organisation of test results used during recipient assessment and post-transplant monitoring.
Which country CAGRs are profiled in the Kidney Transplant Market?
Table 6: Country CAGR Comparison for Kidney Transplant Market (CAGR percentage), 2026 to 2036

| Country | CAGR |
|---|---|
| United States | 3.2% |
| China | 3.1% |
| India | 3.3% |
| Brazil | 4.1% |
| Germany | 2.4% |
| United Kingdom | 2.9% |
Country-wise Analysis
United States Kidney Transplant Market Outlook (2026 to 2036)
US transplant programmes need sufficient clinical capacity for recipients already evaluated for treatment. Preservation, allocation and centre readiness are connected parts of the operating pathway, and the suitability of an individual organ remains clinically important. Suppliers need to support a functioning programme across successive cases.
China Kidney Transplant Market Outlook (2026 to 2036)
China's transplant centres bring specialist surgery, organ coordination and continuing recipient treatment into one purchasing environment, making institutional capability central to market development. A centre may have the operating equipment required for transplantation while still needing trained teams, laboratory support and dependable medicine supply to sustain its programme. Demand therefore follows the service that can actually be delivered to suitable recipients, with donor evaluation and organ availability influencing procedure timing. Commercial opportunities arise around the coordination of these clinical tasks, especially where institutions can maintain consistent assessment and follow-up as their programmes grow.
India Kidney Transplant Market Outlook (2026 to 2036)
Inclusion of a kidney-transplant package within Ayushman Bharat PM-JAY provides an identified financing route for eligible treatment in India, alongside the continuing need for specialist centres and suitable donors. The health ministry's August 2025 announcement also emphasised organ coordination, infrastructure and trained personnel, linking financial access with the practical ability to deliver care. Hospitals need to bring these elements together before a patient can proceed from evaluation to surgery, with continuing medicines and follow-up adding further requirements after discharge.
Brazil Kidney Transplant Market Outlook (2026 to 2036)
Brazil's transplant activity is concentrated within an established network of centres, giving suppliers and service providers a clear institutional route into the market. The national registry recorded 6,697 kidney transplants in 2025, including 5,844 deceased-donor and 853 living-donor procedures, with 162 active centres across 24 states. This service structure makes organ transport, centre readiness and continuing recipient treatment commercially relevant at the network level, while the requirements of an individual centre depend on its donor mix and caseload.
Germany Kidney Transplant Market Outlook (2026 to 2036)
German transplant programmes operate within a mature specialist-care environment where available organs can limit the number of procedures performed even when surgical expertise is established. Hospitals therefore assess preservation needs, donor coordination and recipient preparation together, because an operating slot becomes useful only when the clinical pathway is ready. Continuing immunosuppression and monitoring also create purchasing requirements beyond the initial admission. Against this setting, FMI outlook: 2.4% CAGR, 2026 to 2036. Suppliers can strengthen their position through dependable availability and support for the programme's actual clinical work, while the pace of expansion remains connected to suitable organ supply and the capacity to deliver sustained recipient care.
United Kingdom Kidney Transplant Market Outlook (2026 to 2036)
Paired and pooled donation gives UK transplant teams an additional matching route when an intended living donor cannot donate directly to the associated recipient. NHS Blood and Transplant reported 117 procedures enabled through the UK Living Kidney Sharing Scheme in 2025/26, alongside 984 living-donor and 2,294 deceased-donor kidney transplants. Organ coordination and recipient preparation therefore sit at the centre of purchasing decisions, with medicines and preservation requirements varying along the pathway. Continuing follow-up remains important to the service, extending demand beyond the scheduled operation itself.
Who are the notable companies in the Kidney Transplant Market?
Astellas Pharma; Veloxis Pharmaceuticals; Sanofi; Novartis; XVIVO

Competition follows two connected purchasing cycles: preservation technology supports the recovered organ before implantation, while medicines serve the recipient through continuing treatment. Astellas, Veloxis, Sanofi and Novartis occupy therapeutic roles, with XVIVO positioned around organ preservation. A centre's donor mix, procedure capacity and follow-up service shape which products it requires and how often those purchases recur.
Competitive Benchmarking: Kidney Transplant Market
Table 7: Competitive positioning for the kidney transplant market
| Company | Positioning | Commercial distinction |
|---|---|---|
| Astellas Pharma | Transplant-related medicines | Product indication and treatment role |
| Veloxis Pharmaceuticals | Transplant therapeutics | Defined medicine and access pathway |
| Sanofi | Transplant-related therapeutics | Treatment context and product availability |
| Novartis | Transplant-related medicines | Product scope and ongoing treatment |
| XVIVO | Organ-preservation technology | Kidney-specific equipment and service scope |
Key Developments in the Kidney Transplant Market
- NHS Blood and Transplant's 2025/26 activity report identifies 117 kidney procedures enabled through paired and pooled exchanges, documenting the role of coordinated living-donor matching.
- Brazil's 2025 registry records 6,697 kidney transplants across 162 active centres, showing the network within which procedure-related purchases arise.
- India's health ministry confirmed in August 2025 that a kidney-transplant package had been included in Ayushman Bharat PM-JAY, providing an identified financing route for eligible care.
Key Players in the Kidney Transplant Market
Transplant-related medicines
- Astellas Pharma
Transplant therapeutics
- Veloxis Pharmaceuticals
Transplant-related therapeutics
- Sanofi
Transplant-related medicines
- Novartis
Organ-preservation technology
- XVIVO
Kidney Transplant Market Report Scope
Table 8: Report Scope for Kidney Transplant Market, 2026 to 2036
| Coverage field | Report scope |
|---|---|
| Market definition | The market covers kidney-transplant procedures and organ preservation together with related treatment and services. Kidney-only and multiorgan procedures are distinguished, as are donor sources and active versus total waiting lists. |
| Quantitative units | USD billion |
| Historical reference year | 2025 |
| Forecast period | 2026 to 2036 |
| Market breakdown | Transplant Type; Age Group; End User; Donor Type; Procedure Type; Post-Transplant Care; Region |
| Countries profiled | United States; China; India; Brazil; Germany; United Kingdom |
| Regions covered | North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa |
| Key companies profiled | Astellas Pharma; Veloxis Pharmaceuticals; Sanofi; Novartis; XVIVO |
Kidney Transplant Market Research Methodology
Table 9: Research Methodology for Kidney Transplant Market, 2026 edition
| Method | Approach |
|---|---|
| Market definition | The market covers kidney-transplant procedures and organ preservation together with related treatment and services. Kidney-only and multiorgan procedures are distinguished, as are donor sources and active versus total waiting lists. |
| Secondary research | Public institutional reports, regulator publications, technical literature and supplier documentation provide the operating context for the market. |
| Quantitative coverage | Market values are expressed in USD billion, with a 2025 base value, a 2026 estimate and a projection for 2036. |
| Segment and country assessment | Segment categories retain distinct demand measures, while each country profile is linked with its estimated CAGR for 2026 to 2036. |
| Company comparison | Representative participants are compared by the product or service offered, the customer application and the implementation requirements relevant to procurement. |
Kidney Transplant Market by Segments
Kidney Transplant Market segmented by Transplant Type:
- Living-Donor Kidney Transplant
- Direct Donation Kidney Transplant
- Non-Directed Donation Kidney Transplant
- Paired Exchange Kidney Transplant
- Deceased-Donor Kidney Transplant
- Brain-Dead Donor Transplants
- Cadaveric Organ Allocation Systems
- Direct Donation Kidney Transplant
Kidney Transplant Market segmented by Age Group:
- Adult
- Chronic Kidney Disease Patients
- End-Stage Renal Disease (ESRD) Cases
- Pediatric
- Congenital Kidney Disorder Cases
- Pediatric Renal Failure Patients
- Chronic Kidney Disease Patients
Kidney Transplant Market segmented by End User:
- Hospitals
- Multi-Specialty Hospitals
- Advanced Surgical Units
- Transplant Centres
- Dedicated Organ Transplant Facilities
- High-Volume Transplant Centers
- Academic and Research Institutes
- Clinical Research Programs
- Transplant Innovation Centers
- Multi-Specialty Hospitals
Kidney Transplant Market segmented by Donor Type:
- Living Donors
- Related Donors (Family Members)
- Unrelated Altruistic Donors
- Deceased Donors
- Brain-Dead Donors
- Cardiac Death Donors
- Related Donors (Family Members)
Kidney Transplant Market segmented by Procedure Type:
- Open Kidney Transplant
- Traditional Surgical Approach
- Complex Transplant Cases
- Minimally Invasive Transplant
- Laparoscopic Techniques
- Robotic-Assisted Transplant Surgery
- Traditional Surgical Approach
Kidney Transplant Market segmented by Post-Transplant Care:
- Acute Rejection Management
- Antibody-Mediated Rejection Treatment
- Cell-Mediated Rejection Control
- Infection Management
- Antiviral Prophylaxis
- Bacterial & Fungal Infection Control
- Long-Term Monitoring
- Renal Function Surveillance
- Immunosuppressant Level Monitoring
- Antibody-Mediated Rejection Treatment
Kidney Transplant Market by Region
- North America
- United States
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Western Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Nordics
- Eastern Europe
- Poland
- Czech Republic
- Romania
- Hungary
- East Asia
- China
- Japan
- South Korea
- South Asia and Pacific
- India
- ASEAN
- Australia and New Zealand
- Middle East and Africa
- GCC Countries
- South Africa
- Türkiye
- Israel
Research Sources and Bibliography
- [1] NHS Blood and Transplant. 2026-08-05. Organ Donation and Transplantation Activity Report 2025/26: Kidney
- [2] Brazilian Association of Organ Transplantation. 2026-05. Registro Brasileiro de Transplantes 2025
- [3] Ministry of Health and Family Welfare / PIB. 2025-08-02. 15th Indian Organ Donation Day
This Report Answers
- How large is the Kidney Transplant Market in 2026?
- What is the growth outlook for the Kidney Transplant Market through 2036?
- What is the 2026 share of Living-Donor Kidney Transplant?
- What is the 2026 share of Adult?
- Which profiled market has the highest projected growth?
- Who are the notable participants in the Kidney Transplant Market?
Table of Content
- Key Takeaways
- Market Size and CAGR
- Top Growth Driver
- Fastest Growing Segment
- Leading Region
- Key Companies
- Emerging Opportunities
- Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Analyst Perspective (What is happening? Why now? What should investors know?)
- Key Questions Answered
- How large is the market?
- What is the CAGR?
- What are key trends?
- Which region dominates?
- Who are the leaders?
Read More...
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Expert Input and Fieldwork (Primary Evidence)
- Tooling, Models, and Reference Databases
- Data Engineering and Model Build
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics (Drivers, Restraints, Opportunity, Trends)
- Scenario Forecast (Optimistic, Likely, Conservative)
- Impact Analysis
- AI Impact
- Sustainability Impact
- Regulatory Impact
- Technology Impact
- Consumer / Buyer Analysis
- Purchase Drivers
- Adoption Barriers
- Buyer Journey
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter's Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Global Market Analysis and Forecast, 2021 to 2036
- Historical Market Size Value (USD Billion) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Projections, 2026 to 2036
- Y-o-Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis, 2021 to 2036
- Global Market Analysis and Forecast, By Transplant Type, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Transplant Type, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Transplant Type, 2026 to 2036
- Living-Donor Kidney Transplant
- Direct Donation Kidney Transplant
- Non-Directed Donation Kidney Transplant
- Paired Exchange Kidney Transplant
- Deceased-Donor Kidney Transplant
- Brain-Dead Donor Transplants
- Cadaveric Organ Allocation Systems
- Y-o-Y Growth Trend Analysis By Transplant Type, 2021 to 2025
- Absolute $ Opportunity Analysis By Transplant Type, 2026 to 2036
- Global Market Analysis and Forecast, By Age Group, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Age Group, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Age Group, 2026 to 2036
- Adult
- Chronic Kidney Disease Patients
- End-Stage Renal Disease (ESRD) Cases
- Pediatric
- Congenital Kidney Disorder Cases
- Pediatric Renal Failure Patients
- Y-o-Y Growth Trend Analysis By Age Group, 2021 to 2025
- Absolute $ Opportunity Analysis By Age Group, 2026 to 2036
- Global Market Analysis and Forecast, By End User, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By End User, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By End User, 2026 to 2036
- Hospitals
- Multi-Specialty Hospitals
- Advanced Surgical Units
- Transplant Centres
- Dedicated Organ Transplant Facilities
- High-Volume Transplant Centers
- Academic and Research Institutes
- Clinical Research Programs
- Transplant Innovation Centers
- Y-o-Y Growth Trend Analysis By End User, 2021 to 2025
- Absolute $ Opportunity Analysis By End User, 2026 to 2036
- Global Market Analysis and Forecast, By Donor Type, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Donor Type, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Donor Type, 2026 to 2036
- Living Donors
- Related Donors (Family Members)
- Unrelated Altruistic Donors
- Deceased Donors
- Brain-Dead Donors
- Cardiac Death Donors
- Y-o-Y Growth Trend Analysis By Donor Type, 2021 to 2025
- Absolute $ Opportunity Analysis By Donor Type, 2026 to 2036
- Global Market Analysis and Forecast, By Procedure Type, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Procedure Type, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Procedure Type, 2026 to 2036
- Open Kidney Transplant
- Traditional Surgical Approach
- Complex Transplant Cases
- Minimally Invasive Transplant
- Laparoscopic Techniques
- Robotic-Assisted Transplant Surgery
- Y-o-Y Growth Trend Analysis By Procedure Type, 2021 to 2025
- Absolute $ Opportunity Analysis By Procedure Type, 2026 to 2036
- Global Market Analysis and Forecast, By Post-Transplant Care, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Billion) Analysis By Post-Transplant Care, 2021 to 2025
- Current and Future Market Size Value (USD Billion) Analysis and Forecast By Post-Transplant Care, 2026 to 2036
- Acute Rejection Management
- Antibody-Mediated Rejection Treatment
- Cell-Mediated Rejection Control
- Infection Management
- Antiviral Prophylaxis
- Bacterial & Fungal Infection Control
- Long-Term Monitoring
- Renal Function Surveillance
- Immunosuppressant Level Monitoring
- Y-o-Y Growth Trend Analysis By Post-Transplant Care, 2021 to 2025
- Absolute $ Opportunity Analysis By Post-Transplant Care, 2026 to 2036
- Global Market Analysis and Forecast, By Region, 2021 to 2036
- Introduction
- Historical Market Size Value (USD Billion) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Billion) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis and Forecast, By Country, 2021 to 2036
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- United States
- Canada
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- Latin America Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Mexico
- Argentina
- Chile
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- Western Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- United Kingdom
- Germany
- France
- Italy
- Spain
- Benelux
- Nordics
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- Eastern Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Poland
- Czech Republic
- Romania
- Hungary
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- East Asia Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- South Asia and Pacific Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia and New Zealand
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- Middle East and Africa Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Billion) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Billion) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- GCC Countries
- South Africa
- Türkiye
- Israel
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- By Country
- Market Attractiveness Analysis
- By Country
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Key Takeaways
- Key Countries Market Analysis
- United States
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- United Kingdom
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Australia and New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Türkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- United States
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Transplant Type
- By Age Group
- By End User
- By Donor Type
- By Procedure Type
- By Post-Transplant Care
- Emerging Startups
- Innovation Benchmarking
- Competition Analysis
- Competition Deep Dive
- Astellas Pharma
- Overview
- Product Portfolio
- Profitability by Market Segments
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Veloxis Pharmaceuticals
- Sanofi
- Novartis
- XVIVO
- Astellas Pharma
- Case Studies
- Success Stories
- Recent Developments
- Competition Deep Dive
- Assumptions & Acronyms Used
List of Tables
- Table 1: Global Market Value (USD Billion) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 3: Global Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 4: Global Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 5: Global Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 6: Global Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 7: Global Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 8: North America Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 9: North America Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 10: North America Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 11: North America Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 12: North America Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 13: North America Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 14: North America Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 15: Latin America Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 16: Latin America Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 17: Latin America Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 18: Latin America Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 19: Latin America Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 20: Latin America Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 21: Latin America Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 22: Western Europe Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 23: Western Europe Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 24: Western Europe Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 25: Western Europe Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 26: Western Europe Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 27: Western Europe Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 28: Western Europe Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 29: Eastern Europe Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 30: Eastern Europe Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 31: Eastern Europe Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 32: Eastern Europe Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 33: Eastern Europe Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 34: Eastern Europe Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 35: Eastern Europe Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 36: East Asia Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 37: East Asia Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 38: East Asia Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 39: East Asia Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 40: East Asia Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 41: East Asia Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 42: East Asia Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 43: South Asia and Pacific Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 44: South Asia and Pacific Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 45: South Asia and Pacific Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 46: South Asia and Pacific Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 47: South Asia and Pacific Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 48: South Asia and Pacific Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 49: South Asia and Pacific Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
- Table 50: Middle East and Africa Market Value (USD Billion) Forecast by Country, 2021 to 2036
- Table 51: Middle East and Africa Market Value (USD Billion) Forecast by Transplant Type, 2021 to 2036
- Table 52: Middle East and Africa Market Value (USD Billion) Forecast by Age Group, 2021 to 2036
- Table 53: Middle East and Africa Market Value (USD Billion) Forecast by End User, 2021 to 2036
- Table 54: Middle East and Africa Market Value (USD Billion) Forecast by Donor Type, 2021 to 2036
- Table 55: Middle East and Africa Market Value (USD Billion) Forecast by Procedure Type, 2021 to 2036
- Table 56: Middle East and Africa Market Value (USD Billion) Forecast by Post-Transplant Care, 2021 to 2036
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Billion) Forecast 2021-2036
- Figure 3: Global Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 4: Global Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 5: Global Market Attractiveness Analysis by Transplant Type
- Figure 6: Global Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 7: Global Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 8: Global Market Attractiveness Analysis by Age Group
- Figure 9: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 10: Global Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 11: Global Market Attractiveness Analysis by End User
- Figure 12: Global Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 13: Global Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 14: Global Market Attractiveness Analysis by Donor Type
- Figure 15: Global Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 16: Global Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 17: Global Market Attractiveness Analysis by Procedure Type
- Figure 18: Global Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 19: Global Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 20: Global Market Attractiveness Analysis by Post-Transplant Care
- Figure 21: Global Market Value (USD Billion) Share and BPS Analysis by Region, 2026 and 2036
- Figure 22: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
- Figure 23: Global Market Attractiveness Analysis by Region
- Figure 24: North America Market Incremental Dollar Opportunity, 2026-2036
- Figure 25: Latin America Market Incremental Dollar Opportunity, 2026-2036
- Figure 26: Western Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 27: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 28: East Asia Market Incremental Dollar Opportunity, 2026-2036
- Figure 29: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
- Figure 30: Middle East and Africa Market Incremental Dollar Opportunity, 2026-2036
- Figure 31: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 32: North America Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 33: North America Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 34: North America Market Attractiveness Analysis by Transplant Type
- Figure 35: North America Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 36: North America Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 37: North America Market Attractiveness Analysis by Age Group
- Figure 38: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 39: North America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 40: North America Market Attractiveness Analysis by End User
- Figure 41: North America Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 42: North America Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 43: North America Market Attractiveness Analysis by Donor Type
- Figure 44: North America Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 45: North America Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 46: North America Market Attractiveness Analysis by Procedure Type
- Figure 47: North America Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 48: North America Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 49: North America Market Attractiveness Analysis by Post-Transplant Care
- Figure 50: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 51: Latin America Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 52: Latin America Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 53: Latin America Market Attractiveness Analysis by Transplant Type
- Figure 54: Latin America Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 55: Latin America Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 56: Latin America Market Attractiveness Analysis by Age Group
- Figure 57: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 58: Latin America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 59: Latin America Market Attractiveness Analysis by End User
- Figure 60: Latin America Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 61: Latin America Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 62: Latin America Market Attractiveness Analysis by Donor Type
- Figure 63: Latin America Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 64: Latin America Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 65: Latin America Market Attractiveness Analysis by Procedure Type
- Figure 66: Latin America Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 67: Latin America Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 68: Latin America Market Attractiveness Analysis by Post-Transplant Care
- Figure 69: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 70: Western Europe Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 71: Western Europe Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 72: Western Europe Market Attractiveness Analysis by Transplant Type
- Figure 73: Western Europe Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 74: Western Europe Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 75: Western Europe Market Attractiveness Analysis by Age Group
- Figure 76: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 77: Western Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 78: Western Europe Market Attractiveness Analysis by End User
- Figure 79: Western Europe Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 80: Western Europe Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 81: Western Europe Market Attractiveness Analysis by Donor Type
- Figure 82: Western Europe Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 83: Western Europe Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 84: Western Europe Market Attractiveness Analysis by Procedure Type
- Figure 85: Western Europe Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 86: Western Europe Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 87: Western Europe Market Attractiveness Analysis by Post-Transplant Care
- Figure 88: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 89: Eastern Europe Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 90: Eastern Europe Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 91: Eastern Europe Market Attractiveness Analysis by Transplant Type
- Figure 92: Eastern Europe Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 93: Eastern Europe Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 94: Eastern Europe Market Attractiveness Analysis by Age Group
- Figure 95: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 96: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 97: Eastern Europe Market Attractiveness Analysis by End User
- Figure 98: Eastern Europe Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 99: Eastern Europe Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 100: Eastern Europe Market Attractiveness Analysis by Donor Type
- Figure 101: Eastern Europe Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 102: Eastern Europe Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 103: Eastern Europe Market Attractiveness Analysis by Procedure Type
- Figure 104: Eastern Europe Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 105: Eastern Europe Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 106: Eastern Europe Market Attractiveness Analysis by Post-Transplant Care
- Figure 107: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 108: East Asia Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 109: East Asia Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 110: East Asia Market Attractiveness Analysis by Transplant Type
- Figure 111: East Asia Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 112: East Asia Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 113: East Asia Market Attractiveness Analysis by Age Group
- Figure 114: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 115: East Asia Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 116: East Asia Market Attractiveness Analysis by End User
- Figure 117: East Asia Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 118: East Asia Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 119: East Asia Market Attractiveness Analysis by Donor Type
- Figure 120: East Asia Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 121: East Asia Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 122: East Asia Market Attractiveness Analysis by Procedure Type
- Figure 123: East Asia Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 124: East Asia Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 125: East Asia Market Attractiveness Analysis by Post-Transplant Care
- Figure 126: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 127: South Asia and Pacific Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 128: South Asia and Pacific Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 129: South Asia and Pacific Market Attractiveness Analysis by Transplant Type
- Figure 130: South Asia and Pacific Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 131: South Asia and Pacific Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 132: South Asia and Pacific Market Attractiveness Analysis by Age Group
- Figure 133: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 134: South Asia and Pacific Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 135: South Asia and Pacific Market Attractiveness Analysis by End User
- Figure 136: South Asia and Pacific Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 137: South Asia and Pacific Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 138: South Asia and Pacific Market Attractiveness Analysis by Donor Type
- Figure 139: South Asia and Pacific Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 140: South Asia and Pacific Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 141: South Asia and Pacific Market Attractiveness Analysis by Procedure Type
- Figure 142: South Asia and Pacific Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 143: South Asia and Pacific Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 144: South Asia and Pacific Market Attractiveness Analysis by Post-Transplant Care
- Figure 145: Middle East and Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 146: Middle East and Africa Market Value Share and BPS Analysis by Transplant Type, 2026 and 2036
- Figure 147: Middle East and Africa Market Y-o-Y Growth Comparison by Transplant Type, 2026-2036
- Figure 148: Middle East and Africa Market Attractiveness Analysis by Transplant Type
- Figure 149: Middle East and Africa Market Value Share and BPS Analysis by Age Group, 2026 and 2036
- Figure 150: Middle East and Africa Market Y-o-Y Growth Comparison by Age Group, 2026-2036
- Figure 151: Middle East and Africa Market Attractiveness Analysis by Age Group
- Figure 152: Middle East and Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 153: Middle East and Africa Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 154: Middle East and Africa Market Attractiveness Analysis by End User
- Figure 155: Middle East and Africa Market Value Share and BPS Analysis by Donor Type, 2026 and 2036
- Figure 156: Middle East and Africa Market Y-o-Y Growth Comparison by Donor Type, 2026-2036
- Figure 157: Middle East and Africa Market Attractiveness Analysis by Donor Type
- Figure 158: Middle East and Africa Market Value Share and BPS Analysis by Procedure Type, 2026 and 2036
- Figure 159: Middle East and Africa Market Y-o-Y Growth Comparison by Procedure Type, 2026-2036
- Figure 160: Middle East and Africa Market Attractiveness Analysis by Procedure Type
- Figure 161: Middle East and Africa Market Value Share and BPS Analysis by Post-Transplant Care, 2026 and 2036
- Figure 162: Middle East and Africa Market Y-o-Y Growth Comparison by Post-Transplant Care, 2026-2036
- Figure 163: Middle East and Africa Market Attractiveness Analysis by Post-Transplant Care
- Figure 164: Global Market - Tier Structure Analysis
- Figure 165: Global Market - Company Share Analysis
Frequently Asked Questions
How large is the Kidney Transplant Market in 2026?
The market is estimated at USD 6.4 billion in 2026, compared with USD 6.18 billion in 2025.
What is the growth outlook for the Kidney Transplant Market through 2036?
The market is projected to reach USD 9.6 billion by 2036, representing a CAGR of 4.1% from 2026 to 2036.
What is the 2026 share of Living-Donor Kidney Transplant?
The Living-Donor Kidney Transplant segment is estimated to account for 58.9% of transplant type demand in 2026. Paired exchange connects otherwise incompatible donor-recipient pairs through a coordinated transplant programme, adding a practical matching route within living donation. [1]
What is the 2026 share of Adult?
The Adult segment is estimated to account for 76.4% of age group demand in 2026. Recipient assessment and post-transplant monitoring connect the procedure with a longer course of specialist care and medicine purchasing.
Which profiled market has the highest projected growth?
Brazil has the highest projected rate among the markets profiled, at 4.1% CAGR from 2026 to 2036.
Who are the notable participants in the Kidney Transplant Market?
Representative participants include Astellas Pharma, Veloxis Pharmaceuticals, Sanofi, Novartis, XVIVO.
Preview the report firsthand - request a free sample
Get SampleGet the brochure for pricing and purchase details.
Get PDF